Spending on consumer advertising for top-selling prescription drugs in U.S. favors those with low added benefit; Analysis also revealed that majority of top-selling prescription drugs in the U.S.—more than two-thirds—are rated as having low added benefit compared to other drugs
Virgin Orbit's failed debut UK rocket launch traced to '$100 part:' report
Firefly’s first U.S. Space Force launch targeted for May